Low Expression of p27 Protein Combined with Altered p53 and Rb/p16 Expression Status Is Associated with Increased Expression of Cyclin A and Cyclin B1 in Diffuse Large B-Cell Lymphomas

This publication has 41 references indexed in Scilit:

• Concurrent disruption of p16INK4a and the ARF-p53 pathway predicts poor prognosis in aggressive non-Hodgkin's lymphoma
  Leukemia, 2000
• Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in b-cell non-Hodgkin's lymphoma
  International Journal of Cancer, 2000
• INK4a/ARFLocus Alterations in Human Non-Hodgkin's Lymphomas Mainly Occur in Tumors with Wild-Type p53 Gene
  The American Journal of Pathology, 2000
• Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
  Nature, 2000
• p27 in Cell Cycle Control and Cancer
  Leukemia & Lymphoma, 2000
• Divergent Expression of Cclin-Dependent Kinase Inhibitors (CKI) And p14^ARF/p16β in Non-Hodgkin's Lymphomas and Chronic Lymphocytic Leukemia
  Leukemia & Lymphoma, 2000
• Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma
  Leukemia, 1999
• CDK1 and Cyclin A Expression is Linked to Cell Proliferation and Associated with Prognosis in Non-Hodgkin's Lymphomas
  Leukemia & Lymphoma, 1999
• Loss of p16/INK4A Protein Expression in Non-Hodgkin's Lymphomas Is a Frequent Finding Associated with Tumor Progression
  The American Journal of Pathology, 1998
• Investigation of the RB-1 Tumour Suppressor Gene in a United Kingdom Series of Non-Hodgkin's Lymphomas
  Leukemia & Lymphoma, 1996